FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2576748289> ?p ?o ?g. }

• W2576748289 endingPage "96" @default.
• W2576748289 startingPage "88" @default.
• W2576748289 abstract "Methotrexate (MTX) is an anti-folate drug that has been utilized in both malignant and chronic inflammatory conditions. Doctors are often concerned with a potential adverse outcome when managing patients with acute oral MTX poisoning given its potential for serious adverse reactions at therapeutic doses. However, there is surprisingly little data from acute poisoning cases and more data from the therapeutic use of high-dose MTX.To review pharmacokinetic and pharmacological properties of MTX and systematically review series of acute MTX poisonings and therapeutic studies on high-dose MTX that provide pharmacokinetic or clinical data.An Embase (1974-October 2016) and Medline (1946-October 2016) search was performed by combining MTX and overdose/poison or MTX and toxicity or MTX and high-dose MTX or MTX and bioavailability or pharmacokinetics; 25, 135, 109 and 365 articles were found, respectively, after duplicates were removed. There were 15 papers that provided clinical data on acute ingestion and toxicity that occurred with low-dose administration. Eighteen papers were on high-dose MTX (>1 g per m2 body surface area) used as a single chemotherapy agent which provided pharmacokinetic or clinical data on MTX toxicity. Thirty papers were reviewed to determine the toxic dose, pharmacokinetics, risk factors, clinical symptoms and management of acute MTX toxicity. Given the limited acute poisoning data, a retrospective audit was performed through the consultant records of the New South Wales Poisons Information Centre from April 2004 to July 2015 to examine the clinical syndrome and toxicity of acute oral MTX poisoning. Pharmacokinetics: Reduced MTX bioavailability is a result of saturable absorption. Although maximal bioavailable absorption occurs at a dose of ∼15 mg m-2, splitting the dose increases bioavailability. MTX clearance is proportional to renal function. Acute toxicity: Oncologists prescribe doses up to 12 g m-2 of MTX. Patients treated with an intravenous dose of MTX <1g m-2 do not require folinic acid rescue. MTX toxicity correlates better with duration and extent of exposure than peak serum concentration. Acute oral poisoning: Acute oral MTX poisoning in 177 patients did not report any severe toxicity. In the New South Wales Poisons Information Centre audit data (2004-2015), 51 cases of acute MTX poisoning were reported, of which 15 were accidental paediatric ingestions. The median reported paediatric ingestion was 50 mg (IQR: 10-100; range: 10-150) with a median age of 2 years (IQR: 2-2; range: 1-4). Of the 36 patients with acute deliberate MTX poisoning, median age and dose were 47 years (IQR: 31-62; range: 10-85) and 325 mg (IQR: 85-500; range: 40-1000), respectively. Of the 19 patients who had serum MTX concentrations measured, all were significantly below the concentrations used in oncology and the folinic acid rescue nomogram line and no patient reported adverse sequelae. Management of acute oral poisoning: Due to the low bioavailability of MTX, treatment is not necessary for single ingestions. Oral folinic acid may be used to lower the bioavailability further with large ingestions >1 g m-2. Oral followed by intravenous folinic acid may be used in patients with staggered ingestion >36 h or patients with acute overdose and renal impairment (eGFR <45 mL/min/1.73 m2).As a consequence of saturable absorption MTXs bioavailability is so low that neither accidental paediatric MTX ingestion nor acute deliberate MTX overdose causes toxicity. An acute oral overdose will not provide a bioavailable dose even close to 1 g m-2 of parenteral MTX. Hence, no treatment is required in acute ingestion unless the patient has renal failure or staggered ingestion. There is also no need to monitor MTX concentrations in acute oral MTX poisoning." @default.
• W2576748289 created "2017-01-26" @default.
• W2576748289 creator A5008230554 @default.
• W2576748289 creator A5029961929 @default.
• W2576748289 creator A5040371388 @default.
• W2576748289 date "2017-01-13" @default.
• W2576748289 modified "2023-10-16" @default.
• W2576748289 title "What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?" @default.
• W2576748289 cites W1492120359 @default.
• W2576748289 cites W1549843613 @default.
• W2576748289 cites W1589676276 @default.
• W2576748289 cites W1598956904 @default.
• W2576748289 cites W1664168469 @default.
• W2576748289 cites W1978956528 @default.
• W2576748289 cites W1983554869 @default.
• W2576748289 cites W1985399879 @default.
• W2576748289 cites W1987955143 @default.
• W2576748289 cites W1990318898 @default.
• W2576748289 cites W1990486388 @default.
• W2576748289 cites W1995376945 @default.
• W2576748289 cites W1998280114 @default.
• W2576748289 cites W1998794597 @default.
• W2576748289 cites W2012653512 @default.
• W2576748289 cites W2013426720 @default.
• W2576748289 cites W2016133182 @default.
• W2576748289 cites W2017497764 @default.
• W2576748289 cites W2023073276 @default.
• W2576748289 cites W2023284543 @default.
• W2576748289 cites W2023589406 @default.
• W2576748289 cites W2032992998 @default.
• W2576748289 cites W2033095244 @default.
• W2576748289 cites W2039189448 @default.
• W2576748289 cites W2040344438 @default.
• W2576748289 cites W2044338163 @default.
• W2576748289 cites W2044358251 @default.
• W2576748289 cites W2045786089 @default.
• W2576748289 cites W2050076085 @default.
• W2576748289 cites W2050113646 @default.
• W2576748289 cites W2055021499 @default.
• W2576748289 cites W2060840180 @default.
• W2576748289 cites W2069009549 @default.
• W2576748289 cites W2070781226 @default.
• W2576748289 cites W2071185121 @default.
• W2576748289 cites W2079126927 @default.
• W2576748289 cites W2083614315 @default.
• W2576748289 cites W2086338003 @default.
• W2576748289 cites W2095383299 @default.
• W2576748289 cites W2096767765 @default.
• W2576748289 cites W2104297204 @default.
• W2576748289 cites W2112971111 @default.
• W2576748289 cites W2124815378 @default.
• W2576748289 cites W2138737767 @default.
• W2576748289 cites W2141046729 @default.
• W2576748289 cites W2143828567 @default.
• W2576748289 cites W2145576587 @default.
• W2576748289 cites W2302247390 @default.
• W2576748289 cites W2342769258 @default.
• W2576748289 cites W2415547494 @default.
• W2576748289 cites W2885961944 @default.
• W2576748289 doi "https://doi.org/10.1080/15563650.2016.1271126" @default.
• W2576748289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28084171" @default.
• W2576748289 hasPublicationYear "2017" @default.
• W2576748289 type Work @default.
• W2576748289 sameAs 2576748289 @default.
• W2576748289 citedByCount "29" @default.
• W2576748289 countsByYear W25767482892017 @default.
• W2576748289 countsByYear W25767482892018 @default.
• W2576748289 countsByYear W25767482892019 @default.
• W2576748289 countsByYear W25767482892020 @default.
• W2576748289 countsByYear W25767482892022 @default.
• W2576748289 countsByYear W25767482892023 @default.
• W2576748289 crossrefType "journal-article" @default.
• W2576748289 hasAuthorship W2576748289A5008230554 @default.
• W2576748289 hasAuthorship W2576748289A5029961929 @default.
• W2576748289 hasAuthorship W2576748289A5040371388 @default.
• W2576748289 hasConcept C112705442 @default.
• W2576748289 hasConcept C116263406 @default.
• W2576748289 hasConcept C126322002 @default.
• W2576748289 hasConcept C177713679 @default.
• W2576748289 hasConcept C181389837 @default.
• W2576748289 hasConcept C193230392 @default.
• W2576748289 hasConcept C197934379 @default.
• W2576748289 hasConcept C19831878 @default.
• W2576748289 hasConcept C2780035454 @default.
• W2576748289 hasConcept C2781059491 @default.
• W2576748289 hasConcept C29730261 @default.
• W2576748289 hasConcept C71924100 @default.
• W2576748289 hasConcept C98274493 @default.
• W2576748289 hasConceptScore W2576748289C112705442 @default.
• W2576748289 hasConceptScore W2576748289C116263406 @default.
• W2576748289 hasConceptScore W2576748289C126322002 @default.
• W2576748289 hasConceptScore W2576748289C177713679 @default.
• W2576748289 hasConceptScore W2576748289C181389837 @default.
• W2576748289 hasConceptScore W2576748289C193230392 @default.
• W2576748289 hasConceptScore W2576748289C197934379 @default.
• W2576748289 hasConceptScore W2576748289C19831878 @default.
• W2576748289 hasConceptScore W2576748289C2780035454 @default.
• W2576748289 hasConceptScore W2576748289C2781059491 @default.

• next